RNAi screen in Drosophila larvae identifies histone deacetylase 3 as a positive regulator of the hsp70 heat shock gene expression during heat shock

por Achary, Bhavana G., Campbell, Katie M., Co, Ivy S., Gilmour, David S.
Publicado 2014

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

por Campbell, Katie M., Steiner, Gabriela, Wells, Daniel K., Ribas, Antoni, Kalbasi, Anusha
Publicado en bioRxiv (2020)

Best practices for bioinformatic characterization of neoantigens for clinical utility

por Richters, Megan M., Xia, Huiming, Campbell, Katie M., Gillanders, William E., Griffith, Obi L., Griffith, Malachi
Publicado en Genome Med (2019)

GenVisR: Genomic Visualizations in R

por Skidmore, Zachary L., Wagner, Alex H., Lesurf, Robert, Campbell, Katie M., Kunisaki, Jason, Griffith, Obi L., Griffith, Malachi
Publicado en Bioinformatics (2016)

Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy

por Nowicki, Theodore S., Farrell, Colin, Morselli, Marco, Rubbi, Liudmilla, Campbell, Katie M., Macabali, Mignonette H., Berent-Maoz, Beata, Comin-Anduix, Begoña, Pellegrini, Matteo, Ribas, Antoni
Publicado en Cancer Discov (2020)

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

por Ribas, Antoni, Sengupta, Rajarshi, Locke, Trevan, Zaidi, Sayyed Kaleem, Campbell, Katie M., Carethers, John M., Jaffee, Elizabeth M., Wherry, E. John, Soria, Jean-Charles, D’Souza, Gypsyamber
Publicado en Cancer Discov (2020)

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

por Campbell, Katie M., O’Leary, Kathleen A., Rugowski, Debra E., Mulligan, William A., Barnell, Erica K., Skidmore, Zachary L., Krysiak, Kilannin, Griffith, Malachi, Schuler, Linda A., Griffith, Obi L.
Publicado en Cell Rep (2019)

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

por Ribas, Antoni, Algazi, Alain, Ascierto, Paolo A., Butler, Marcus O., Chandra, Sunandana, Gordon, Michael, Hernandez-Aya, Leonel, Lawrence, Donald, Lutzky, Jose, Miller, Wilson H., Campbell, Katie M., Delafont, Bruno, Marshall, Shannon, Mueller, Nancy, Robert, Caroline
Publicado en Nat Commun (2020)

A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data

por Ainscough, Benjamin J., Barnell, Erica K., Ronning, Peter, Campbell, Katie M., Wagner, Alex H., Fehniger, Todd A., Dunn, Gavin P., Uppaluri, Ravindra, Govindan, Ramaswamy, Rohan, Thomas E., Griffith, Malachi, Mardis, Elaine R., Swamidass, S. Joshua, Griffith, Obi L.
Publicado en Nat Genet (2018)

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

por Mudianto, Tenny, Campbell, Katie M., Webb, Jason, Zolkind, Paul, Skidmore, Zachary L., Riley, Rachel, Barnell, Erica K., Ozgenc, Ibrahim, Giri, Tusar, Dunn, Gavin P., Adkins, Douglas R., Griffith, Malachi, Egloff, Ann Marie, Griffith, Obi L, Uppaluri, Ravindra
Publicado en Clin Cancer Res (2021)

Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity

por Campbell, Katie M., Lin, Tianxiang, Zolkind, Paul, Barnell, Erica K., Skidmore, Zachary L., Winkler, Ashley E., Law, Jonathan H., Mardis, Elaine R., Wartman, Lukas D., Adkins, Douglas R., Chernock, Rebecca D., Griffith, Malachi, Uppaluri, Ravindra, Griffith, Obi L.
Publicado en Cell Rep (2018)

DGIdb 2.0: mining clinically relevant drug–gene interactions

por Wagner, Alex H., Coffman, Adam C., Ainscough, Benjamin J., Spies, Nicholas C., Skidmore, Zachary L., Campbell, Katie M., Krysiak, Kilannin, Pan, Deng, McMichael, Joshua F., Eldred, James M., Walker, Jason R., Wilson, Richard K., Mardis, Elaine R., Griffith, Malachi, Griffith, Obi L.
Publicado en Nucleic Acids Res (2016)

Melorheostosis: Exome Sequencing Of An Associated Dermatosis Implicates Postzygotic Mosaicism Of Mutated KRAS

por Whyte, Michael P., Griffith, Malachi, Trani, Lee, Mumm, Steven, Gottesman, Gary S., McAlister, William H., Krysiak, Kilannin, Lesurf, Robert, Skidmore, Zachary L., Campbell, Katie M, Rosman, Ilana S., Bayliss, Susan, Bijanki, Vinieth N., Nenninger, Angela, Van Tine, Brian A., Griffith, Obi L., Mardis, Elaine R.
Publicado en Bone (2017)

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

por Kalbasi, Anusha, Tariveranmoshabad, Mito, Hakimi, Kevin, Kremer, Sarah, Campbell, Katie M., Funes, Juan M., Vega-Crespo, Agustin, Parisi, Giulia, Champekar, Ameya, Nguyen, Christine, Torrejon, Davis, Shin, Daniel, Zaretsky, Jesse M., Damoiseaux, Robert D., Speiser, Daniel E., Lopez-Casas, Pedro P., Quintero, Marisol, Ribas, Antoni
Publicado en Sci Transl Med (2020)

Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes

por Barnell, Erica K., Waalkes, Adam, Mosior, Matt C., Penewit, Kelsi, Cotto, Kelsy C., Danos, Arpad M., Sheta, Lana M., Campbell, Katie M., Krysiak, Kilannin, Rieke, Damian, Spies, Nicholas C., Skidmore, Zachary L., Pritchard, Colin C., Fehniger, Todd A., Uppaluri, Ravindra, Govindan, Ramaswamy, Griffith, Malachi, Salipante, Stephen J., Griffith, Obi L.
Publicado en JCO Clin Cancer Inform (2019)

Overcoming genetically-based resistance mechanisms to PD-1 blockade

por Torrejon, Davis Y., Abril-Rodriguez, Gabriel, Champhekar, Ameya S., Tsoi, Jennifer, Campbell, Katie M., Kalbasi, Anusha, Parisi, Giulia, Zarestsky, Jesse M., Garcia-Diaz, Angel, Puig-Saus, Cristina, Cheung-Lau, Gardenia, Wohlwender, Thomas, Krystofinski, Paige, Vega-Crespo, Agustin, Lee, Christopher M., Mascaro, Pau, Grasso, Catherine S., Berent-Maoz, Beata, Comin-Anduix, Begoña, Hu-Lieskovan, Siwen, Ribas, Antoni
Publicado en Cancer Discov (2020)

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples

por Barnell, Erica K., Ronning, Peter, Campbell, Katie M., Krysiak, Kilannin, Ainscough, Benjamin J., Sheta, Lana M., Pema, Shahil P., Schmidt, Alina D., Richters, Megan, Cotto, Kelsy C., Danos, Arpad M., Ramirez, Cody, Skidmore, Zachary L., Spies, Nicholas C., Hundal, Jasreet, Sediqzad, Malik S., Kunisaki, Jason, Gomez, Felicia, Trani, Lee, Matlock, Matthew, Wagner, Alex H., Swamidass, S. Joshua, Griffith, Malachi, Griffith, Obi L.
Publicado en Genet Med (2018)

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

por Wells, Daniel K., van Buuren, Marit M., Dang, Kristen K., Hubbard-Lucey, Vanessa M., Sheehan, Kathleen C.F., Campbell, Katie M., Lamb, Andrew, Ward, Jeffrey P., Sidney, John, Blazquez, Ana B., Rech, Andrew J., Zaretsky, Jesse M., Comin-Anduix, Begonya, Ng, Alphonsus H.C., Chour, William, Yu, Thomas V., Rizvi, Hira, Chen, Jia M., Manning, Patrice, Steiner, Gabriela M., Doan, Xengie C., Guinney, Justin, Kolom, Adam, Selinsky, Cheryl, Ribas, Antoni, Hellmann, Matthew D., Hacohen, Nir, Sette, Alessandro, Heath, James R., Bhardwaj, Nina, Ramsdell, Fred, Schreiber, Robert D., Schumacher, Ton N., Kvistborg, Pia, Defranoux, Nadine A.
Publicado en Cell (2020)

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B lymphoblastic leukemia

por Griffith, Malachi, Griffith, Obi L., Krysiak, Kilannin, Skidmore, Zachary L., Christopher, Matthew J., Klco, Jeffery M., Ramu, Avinash, Lamprecht, Tamara L., Wagner, Alex H., Campbell, Katie M., Lesurf, Robert, Hundal, Jasreet, Zhang, Jin, Spies, Nicholas C., Ainscough, Benjamin J., Larson, David E., Heath, Sharon E., Fronick, Catrina, O'Laughlin, Shelly, Fulton, Robert, Magrini, Vincent, McGrath, Sean, Smith, Scott M., Miller, Christopher A., Maher, Christopher A., Payton, Jacqueline E., Walker, Jason R., Eldred, James M., Walter, Matthew J., Link, Daniel C., Graubert, Timothy A., Westervelt, Peter, Kulkarni, Shashikant, DiPersio, John F., Mardis, Elaine R., Wilson, Richard K., Ley, Timothy J.
Publicado en Exp Hematol (2016)

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

por Uppaluri, Ravindra, Campbell, Katie M., Egloff, Ann Marie, Zolkind, Paul, Skidmore, Zachary L., Nussenbaum, Brian, Paniello, Randal C., Rich, Jason T., Jackson, Ryan, Pipkorn, Patrik, Michel, Loren P., Ley, Jessica, Oppelt, Peter, Dunn, Gavin P., Barnell, Erica K., Spies, Nicholas C., Lin, Tianxiang, Li, Tiantian, Mulder, David T., Hanna, Youstina, Cirlan, Iulia, Pugh, Trevor J., Mudianto, Tenny, Riley, Rachel, Zhou, Liye, Jo, Vickie, Stachler, Matthew, Hanna, Glenn J., Kass, Jason, Haddad, Robert, Schoenfeld, Jonathan D., Gjini, Evisa, Lako, Ana, Thorstad, Wade, Gay, Hiram A., Daly, Mackenzie, Rodig, Scott J., Hagemann, Ian S., Kallogjeri, Dorina, Piccirillo, Jay F., Chernock, Rebecca D., Griffith, Malachi, Griffith, Obi L., Adkins, Douglas R.
Publicado en Clin Cancer Res (2020)